Academic publisher SAGE has extended its suite of Therapeutic Advances journals with the launch of a further title - Therapeutic Advances in Psychopharmacology, published in association with the British Association for Psychopharmacology.
Therapeutic Advances in Psychopharmacology focuses on anticonvulsants, psychostimulants and drug treatment for psychological disorders such as depression, mania, psychosis, anxiety, attention deficit disorder, alcohol/opiate withdrawal, behavioural disturbance, dementia, substance misuse, hypnotics and mood stabilisers.
International in scope, the journal follows the format of the existing eleven Therapeutic Advances titles, offering rapid peer review and publication, with manuscripts published online within at most seven weeks of acceptance. The journal publishes six issues per year and will be freely available on the SAGE Journals Online platform.
Search for more Academic Journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
